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This paper investigated the effectiveness of an inpatient movement disorders program for patients with atypical parkinsonism, who
typically respond poorly to pharmacologic intervention and are challenging to rehabilitate as outpatients. Ninety-one patients
with atypical parkinsonism participated in an inpatient movement disorders program. Patients received physical, occupational,
and speech therapy for 3 hours/day, 5 to 7 days/week, and pharmacologic adjustments based on daily observation and data.
Differences between admission and discharge scores were analyzed for the functional independence measure (FIM), timed up
and go test (TUG), two-minute walk test (TMW), Berg balance scale (BBS) and finger tapping test (FT), and all showed significant
improvement on discharge (P > .001). Clinically significant improvements in total FIM score were evident in 74% of the patients.
Results were similar for ten patients whose medications were not adjusted. Patients with atypical parkinsonism benefit from an
inpatient interdisciplinary movement disorders program to improve functional status.
1. Introduction
Atypical parkinsonism is used to describe disorders charac-
terized by parkinsonism—tremor, rigidity, akinesia, and pos-
tural instability—but not caused by Parkinson’s disease (PD).
These disorders often include other prominent features. The
term includes progressive supranuclear palsy (PSP), multiple
system atrophy (MSA), Lewy body dementia (LBD), corti-
cobasal degeneration (CBD), vascular parkinsonism, drug-
induced parkinsonism, and parkinsonism secondary to in-
fection and other causes. PSP is characterized by parkinson-
ism along with a supranuclear vertical gaze palsy and early
onset of balance problems and falls. The hallmark features of
MSA include parkinsonism, autonomic instability, and cere-
bellar and corticospinal deficits. LBD has similar pathology
to PD; however, accumulation of Lewy bodies in areas out-
side the substantia nigra leads to hallucinations, cognitive
impairment and dementia prior to the onset of parkinson-
ism. Features of CBD include asymmetric parkinsonism,
apraxia, alien limb phenomenon, aphasia, and sensory de-
ficits. Vascular parkinsonism is due to lacunar infarcts in the
basal ganglia and can be distinguished from PD by an abrupt
onset or stepwise deterioration and development of parkin-
sonism and evidence of neurovascular disease. Drug-induced
parkinsonism is often due to antipsychotics or antiemetics
and usually resolves with cessation of the offending drug
[1, 2].
Treatment of PD involves medications that increase dop-
amine in the basal ganglia. However, there has been less suc-
cess with pharmacologic treatment in atypical parkinsonism
[1, 3–5]. Previous studies have shown physical therapy to be
an effective adjunctive treatment in patients with PD [6, 7]
but there have only been a handful of case reports and studies
investigating the efficacy of nonpharmacologic therapy in
atypical parkinsonism patients.
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Case reports and studies have shown subjective and ob-
jective improvements in gait, balance, and patient safety in
patients with PSP [8–12] and in a patient with mixed CBD
and PSP [13]. Similar improvements in gait, balance, trans-
fers, and stability were seen in case reports of physical therapy
intervention in patients with MSA [14, 15]. Timed up and
go, functional reach test, 360-degree turn, and 50 foot timed
walk are examples of some of the improved objective meas-
ures. Another case report showed improvement in activities
of daily life (ADLs) and finger manipulation after repetitive
finger exercises in a patient with CBD [16]. A small pilot ran-
domized controlled trial showed significant improvement in
MSA patients after receiving individualized outpatient occu-
pational therapy [17].
Regarding intensive inpatient programs, a prior study by
Ellis et al. investigated the effectiveness of an inpatient re-
habilitation program for people with PD. In the study, medi-
cation was adjusted and interdisciplinary rehabilitation pro-
gram was provided to optimize patients’ functional ability.
Significant improvements were noted in all outcome mea-
sures. Patients who did not have changes made to their medi-
cations also showed significant improvements in total,
motor, and cognitive functional independence measure
(FIM) scores [18].
The purpose of this study was to investigate the effec-
tiveness of an inpatient movement disorders program in im-
proving functional status for patients with atypical parkin-
sonism and to determine whether or not these findings
were clinically meaningful.We hypothesized that people with
atypical parkinsonism would show statistically and clinically
significant improvements in functional status after partici-
pating in such a program.
2. Methods
2.1. Design and Subjects. A pretest-posttest design was used
to determine the effectiveness of a movement disorder pro-
gram for patients admitted to an inpatient rehabilitation hos-
pital with the diagnosis of atypical parkinsonism. Patients
were admitted from home, acute care facilities, skilled nurs-
ing facilities, or assisted living between January 2004 and
August 2008. They carried diagnoses, determined by a neuro-
logist specializing in movement disorders, which fall under
the term “atypical parkinsonism” as described above. They
were at least 18 years old and were given a Hoehn and Yahr
stage I to V for classification of PD. A total of 91 subjects were
admitted to the program. Baseline characteristics are listed in
Table 1.
2.2. Outcome Measures. Primary outcomes were FIM total
score. Secondary outcomes included FIM motor score, FIM
cognitive score, 2-minute walk test (TMW), Timed “up and
go” test (TUG) Berg balance score, and finger tapping test
(FT).
The FIM is a widely used 18-item assessment of disability
among inpatient rehabilitation patients. The FIM measures
ability to perform basic life activities, such as self-care, sphin-
cter control, transfers, locomotion, communication, and
Table 1: Patient baseline characteristics.
Characteristic
Age—y, mean (SD) n = 91 76.6 (7.7)
Disease duration—y, mean (SD) n = 91 5.7 (4.4)
Sex no. (%) men/women n = 91 53 (58.2)/38 (41.8)
Race no. (%) white n = 91 84 (92.3)
Education no. (%) ≤ bachelor’s/
>bachelor’s n = 75 51 (56)/24 (26.4)
Hoehn and Yahr stage no. (%) n = 85
I 0 (0)
II 0 (0)
III 26 (28.6)
IV 43 (47.3)
V 16 (17.6)
Length of stay—d, mean (SD) 24.4 (11.9)
Diagnosis no. (%) n = 91a
Vascular parkinsonism 25 (27.5)
MSA 19 (20.9)
PSP 4 (4.4)
Medication related 2 (2.2)
LBD 1 (1.1)
CBD 1 (1.1)
Toxin 1 (1.1)
Unknown 38 (41.8)
a
MSA: multiple system atrophy, PSP: progressive supranuclear palsy, LBD:
Lewy body dementia, and CBD: corticobasal dementia.
social cognition. Each item is scored on a scale from 1 to 7,
in which 1 is patient requires total assistance to complete the
task and 7 is complete independence. The FIM can be divided
into 2 sections: motor (13 items) and cognitive (5 items). It
has been shown to have good reliability and validity [19].
The TMW is performed by asking subjects to walk as far
as they can in 2 minutes. Patients with PD have been shown
to cover less distance than age-matched controls [20].
The TUG assesses a patient’s ability to transfer from sitt-
ing to standing, ambulate, and make a turn. Patients are tim-
ed while rising from a chair, walking 3m, turning, walking
back to the chair, and sitting down. It has been shown to have
high interrater reliability for subjects with PD [21]. Subjects
were allowed to use an assistive device if necessary for the
TMW and the TUG.
The BBS is a 14-item scale assessing balance while sitting,
standing, turning, and reaching forward. Items are rated
from 0 to 4, with 0 meaning the subject needs assistance or is
unable to perform the task and 4 meaning the subject can
perform the task safely and independently. It has been shown
to be reliable and valid in patients with PD [22, 23]. Minimal
detectable change (MCD) has been found to be +/−6 points
among patients who have suffered a stroke [24] and +/−5
points in patients with PD [25].
The FT is a timed test useful in assessing the impact of
bradykinesia on rapid alternating movements of the upper
extremity. Two buttons are attached to a counter 30 cm apart.
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Subjects are asked to alternate tapping each button with their
left hand for one minute. The sum of the taps is the score for
that hand. The test is repeated with the right hand. The FT
has been shown to have good validity and reliability and is
able to distinguish normal subjects from those with PD [26].
2.3. Intervention. A multidisciplinary team consisting of
neurologists specializing in movement disorders and neuro-
rehabilitation, physical therapists, occupational therapists,
speech-language pathologists, nurses, and case managers
provided a comprehensive rehabilitation program for pa-
tients admitted to the hospital.
All outcome measures were obtained at admission and
discharge, as well as daily measurements of TMW and TUG
at the peak and troughs of medication cycles. The same ther-
apists administered interventions and outcome measures.
Weekly rounds were conducted to allow the whole team to
evaluate the data and discuss the patients’ status. Decisions
regarding changes to medications or rehabilitation interven-
tions were made at this time. Subjects’ responses to medica-
tion adjustments were discussed further at weekly movement
disorder meetings. Adjustments were made to subjects’ ther-
apy and medications during the entire length of stay at the
hospital. Medication adjustments included increases or de-
creases in Parkinson’s disease medications to optimize peak
performance. Those medications included carbidopa/ lev-
odopa, monoamine oxidase inhibitors, catechol-o methyl-
transferase inhibitors and amantadine.
Subjects received individually tailored physical, occupa-
tional, and speech therapy for a minimum of 3 hours per day
for 5 to 7 days per week. Therapy was provided on an indi-
vidual and group basis. Interventions included external cue-
ing to improve gait speed, step length and cadence [27–30],
cognitive movement strategies during task-based training to
improve mobility, balance and transfers [6, 31–33], resistive
exercises [34], exercises for joint mobility [35, 36], and
speech therapy to improve voice volume and clarity [37, 38].
A more detailed description of the intervention is provided
in Table 2.
2.4. Data Analysis. Means, standard deviations, and fre-
quency distributions were calculated for subjects’ baseline
characteristics, length of stay, and disposition. The efficacy
of the intervention was evaluated by comparing admission
and discharge mean scores for each of the outcomemeasures.
Two-tailed paired t tests were conducted with an alpha level
set at 0.05. A Bonferroni-adjusted type I error rate (α = 0.007)
was applied to all t tests. Results were calculated for patients
who received rehabilitation along with PD medication ad-
justments and for patients who received rehabilitation only.
Clinically significant improvement was determined based on
a total FIM score change of ≥22, which has been associated
with the minimal clinically important difference in people
who have suffered a stroke [39]. In this study a change from
admission of more than 22 was considered to be clinically
meaningful.
3. Results
3.1. Subjects. Ninety-one subjects with atypical parkinson-
ism underwent rehabilitation therapy. Average age at admis-
sion was 76.5 years (SD 0.81), and they had been carrying
the diagnosis of parkinsonism for an average of 5.7 years
(SD 0.55). Of the 91 subjects with atypical parkinsonism, 25
(27.5%) had vascular parkinsonism, 19 (20.9%) had MSA, 4
(4.4%) had PSP, and the remaining cases were either medi-
cation related, due to LBD, CBD, toxin exposure or were un-
known. Eighty-five of the subjects were Hoehn and Yahr
stages III-V. Six subjects were not evaluated using Hoehn
and Yahr (Table 1). The rehabilitation team made changes
to 81 subjects’ medications while receiving physical therapy.
Ten subjects underwent physical rehabilitation only with no
changes to their medications. Length of stay varied from one
to six weeks with an average stay of 2.5 weeks.
3.2. Outcomes for All Patients. Statistically significant im-
provements were made in all outcome measures over the
course of the rehabilitation program (Table 3). Total FIM
score increased 29.5 points (95% CI = 26.4–32.5). Addition-
ally, motor FIM improved 25.9 points (95% CI = 23.4–28.5)
and cognitive FIM improved 3.5 points (95% CI = 2.6–4.4).
TUG decreased by 39.4 seconds (95% CI = 20.6–58.2), TMW
lengthened by 63.5 feet (95% CI = 44.3–82.9), and Berg
balance scale scores improved 7.5 points (95% CI = 4.3–
10.6). Left and right finger tapping improved by 11.5 taps
(95% CI = 6.7–16.1) and 10.8 taps (95% CI = 5.8–16.1), res-
pectively.
Previous studies have shown the minimal clinically im-
portant difference of total FIM to be 22 [39]. Using this cut-
off, sixty-five (74%) patients made clinically meaningful im-
provements in total FIM.
3.3. Outcomes for Patients Receiving Rehabilitation Only and
No Changes to Medication. Statistically significant improve-
ments were made in all but left finger tapping for the 10
patients who received rehabilitation only (Table 4). Analysis
showed an improvement of 32.1 (95% CI = 22.8–41.3) for
total FIM, 28.6 (95% CI = 19.8–37.3) for motor FIM, and
3.5 (95% CI = 1.7–5.2) for cognitive FIM. TUG decreased by
52 seconds on average (95% CI = 13.1–91.0), TMW length
increased by 76 feet (95% CI = 27.4–124.5), and right finger
tapping improved by 19.6 taps (95% CI = 3.4–25.7). Left
finger tapping increased on average 7.8 taps, but results were
not statistically significant (95% CI = −9.7–25.4).
4. Discussion
This study investigated the effectiveness of an interdisci-
plinary inpatient rehabilitation program for patients with
atypical parkinsonism. Our results showed improvements in
total FIM, motor FIM, cognitive FIM, TMW, TUG, BBS, and
left and right FT. Among patients who received rehabilitation
only, without changes to their medication regimens, statisti-
cally significant improvement in all but left FT was observed.
Clinically meaningful improvement, defined by a change in
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Table 2: Description of interventions.
Functional training
Rolling from supine position to sitting position and from sitting position to supine position.
Transferring from sitting position to standing position, from chair to bed, and from chair to toilet.
Dressing and grooming.
Balance: reactive and anticipatory within functional contexts.
Gait training
Walking with external auditory cues from a metronome to optimize gait speed and cadence;
increasing cadence by 10% over baseline and progressing until cadence approaches normal or
until subject reaches maximum capacity.
Reducing freezing (context specific: doorways, thresholds, and narrow spaces) with visual cues in
the form of lines on the floor from tape or laser beams.
Reducing freezing (context specific: doorways, thresholds, and narrow spaces) with visual cues in
the form of lines on the floor from tape or laser beams.
Improving adaptation (various walking surfaces, obstacles in the environment, starting and
stopping, and turning head while walking).
Curb negotiation and stair climbing.
Range of motion, flexibility,
strengthening exercises
Range of motion (increase trunk extension and rotation).
Stretching (hip flexor, hamstring, and gastrocnemius muscles).
Strengthening (trunk and hip postural muscles and knee and ankle extensor muscles).
Speech exercises
Exercises to improve vocal rate control.
Exercises to improve phonation.
Table 3: All patients.
Measure (n)a Admission mean (SD) Discharge mean (SD) Change (95% CI)
Total FIM (88) 41.3 (15.7) 70.8 (21.4) 29.5 (28.4, 32.5)
Motor FIM (88) 23.6 (11) 49.6 (16.6) 25.9 (23.4, 28.5)
Cognitive FIM (87) 17.7 (6.1) 21.2 (5.8) 3.5 (2.6, 4.4)
TUG (60) 81.5 s (89.4) 42.0 s (46.9) −39.4 s (−20.6, −28.2)
TMW (60) 138.9 ft (76.9) 202.5 ft (96.9) 63.5 ft (44.2, 82.9)
BBS (28) 22 (12.2) 29.5 (13.4) 7.5 (4.3, 10.6)
Left FT (51) 60.2 (23.3) 71.7 (24.8) 11.5 (6.7, 16.1)
Right FT (50) 68.3 (27) 79.3 (30) 10.9 (5.8, 16.1)
a
FIM: functional independence measure, TUG: timed up and go, TMW: 2-minute walk, BBS: berg balance scale, and FT: finger tap.
total FIM of greater than 22, was also observed in 74% of
patients. These results imply that patients with atypical par-
kinsonism can show significant improvement in function
after receiving intensive inpatient multidisciplinary therapy
including rehabilitative and pharmacologic interventions.
Patients with atypical parkinsonism are difficult to man-
age on an outpatient basis. The complexity of their symp-
toms, the added cognitive and autonomic deficits, the poor
response to most PD pharmacological agents, and the rela-
tively rapid decline in status contribute to the challenges in
managing these patients particularly as the disease progress-
es. This study highlights the benefits of an interdisciplinary
rehabilitation program in addition to medication adjust-
ments in an inpatient setting, where patients could be ob-
served over a 24-hour period, 7 days per week by health care
professionals with expertise in movement disorders. Objec-
tive measures taken daily during peak and troughs of medi-
cation cycle allowed an objective, systematic assessment
of function. This data was used to guide the decision-
making process regarding pharmacological adjustments and
the focus of rehabilitation strategies.
Strengths of our study include the large sample size, the
variety of disorders, and the advanced disability stages of
the patients. Other studies investigating the effectiveness of
rehabilitation have been case reports, small pretest-posttest
trials with a sample size of 19 or less, and a pilot RCT
with a sample size of 17 [6, 8–10, 12–15]. In addition, most
of the studies included subjects with PSP, whereas our study
sampled across categories of atypical parkinsonism and
included primarily vascular parkinsonism and MSA. Our
patients were also at higher levels of disability and all were
Hoehn and Yahr stages III to V, suggesting that functional
gains can be made in these patients with complex symptoms
in later stages of the disease.
Limitations of the study include lack of a control group
and prescribing rehabilitation while simultaneously chang-
ing medications. We are unable to distinguish what effects
were due purely to physical rehabilitation. However, our
smaller group of 10 patients who received rehabilitation only
did show significant improvement, but larger studies should
be conducted to address the particular effects of rehabilita-
tion alone. It is also difficult to assess whether the intensive
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Table 4: Patients receiving rehabilitation only.
Measure (n)a Admission mean (SD) Discharge mean (SD) Change (95% CI)
Total FIM (10) 38.3 (13.4) 70.4 (23.4) 32.1 (22.8, 41.3)
Motor FIM (10) 21.2 (7.8) 49.6 (17.6) 28.6 (19.8, 37.2)
Cognitive FIM (10) 17.1 (6.1) 20.6 (6.1) 3.5 (1.7, 5.2)
TUG (10) 83.4 s (61.5) 31.3 s (10.1) −52.1 s (−13.7, −91.0)
TMW (9) 114.4 ft (77.6) 190.4 ft (68.4) 76.0 ft (27.4, 124.5)
Left FT (8) 61.5 (19.8) 69.3 (13.4) 7.8 (−9.7, 25.4)
Right FT (8) 67.2 (24.8) 86.8 (24.9) 19.6 (3.4, 35.7)
a
FIM: functional independence measure, TUG: timed up and go, TMW: 2-minute walk, BBS: berg balance scale, and FT: finger tap.
nature of the program itself had any effect on the subjects’
improvement. The higher frequency of assessments and ther-
apy sessions in an inpatient settingmay have continued to the
improvements observed. Factors such as treatment intensity,
the availability of objective data for treatment decisions
and goal setting, and the expertise and frequent commu-
nication of the interdisciplinary team were not individually
assessed. Further studies comparing specialized interdisci-
plinary movement disorder rehabilitation programs such as
the program described in this study with more traditional
standard rehabilitative care would help clarify this question.
Another limitation of our study is the lack of long-term
followup data. It is unknown if the gains made during the
rehabilitation admission were sustained following discharge.
One study of patients with idiopathic PD in Hoehn and
Yahr stages II and III who participated in an inpatient exer-
cise training and muscle strengthening program sustained
improvements in quality of life at follow-up [40]. Lastly, the
gains in the total FIM used to assess clinically meaningful im-
provement were extrapolated from the stroke literature [39],
as this has not been derived in parkinsonian patients.
While our study demonstrated that patients with atypical
parkinsonism can benefit from an intensive inpatient rehabi-
litation program, further studies are needed to look at the
long-term gains. In addition, research is needed to assess
the efficacy of inpatient rehabilitation programs on atypical
parkinsonism patients with earlier stages of disease and their
effect on the progression of their disorders.
References
[1] C. W. Chadwick and M. J. Aminoff, “Clinical differentiation
of parkinsonian syndromes: prognostic and therapeutic rele-
vance,” American Journal of Medicine, vol. 117, no. 6, pp. 412–
419, 2004.
[2] I. Litvan, K. P. Bhatia, D. J. Burn et al., “Movement disor-
ders society scientific issues committee report: SIC task force-
appraisal of clinical diagnostic criteria for Parkinsonian dis-
orders,” Movement Disorders, vol. 18, no. 5, pp. 467–486, 2003.
[3] I. G. McKeith, D. W. Dickson, J. Lowe et al., “Diagnosis and
management of dementia with Lewy bodies: third report of the
DLB consortium,” Neurology, vol. 65, no. 12, pp. 1863–1872,
2005.
[4] C. Colosimo and F. R. Pezzella, “The symptomatic treatment
of multiple system atrophy,” European Journal of Neurology,
vol. 9, no. 3, pp. 195–199, 2002.
[5] A. E. Lang, “Treatment of progressive supranuclear palsy and-
corticobasal degeneration,” Movement Disorders, vol. 20, sup-
plement 12, pp. S83–S91, 2005.
[6] G. Kwakkel, C. J. T. de Goede, and E. E. H. vanWegen, “Impact
of physical therapy for Parkinson’s disease: a critical review
of the literature,” Parkinsonism and Related Disorders, vol. 13,
supplement 3, pp. S478–S487, 2007.
[7] C. J. T. de Goede, S. H. J. Keus, G. Kwakkel, and R. C. Wage-
naar, “The effects of physical therapy in Parkinson’s disease: a
research synthesis,” Archives of Physical Medicine and Rehabil-
itation, vol. 82, no. 4, pp. 509–515, 2001.
[8] K. L. Izzo, P. DiLorenzo, and A. Roth, “Rehabilitation in pro-
gressive supranuclear palsy: case report,” Archives of Physical
Medicine and Rehabilitation, vol. 67, no. 7, pp. 473–476, 1986.
[9] J. Sosner, G. C.Wall, and J. Sznajder, “Progressive supranuclear
palsy: clinical presentation and rehabilitation of two patients,”
Archives of Physical Medicine and Rehabilitation, vol. 74, no. 5,
pp. 537–539, 1993.
[10] M. Suteerawattananon, B. MacNeill, and E. J. Protas, “Sup-
ported treadmill training for gait and balance in a patient with
progressive supranuclear palsy,” Physical Therapy, vol. 82, no.
5, pp. 485–495, 2002.
[11] C. Zampieri and R. P. Di Fabio, “Balance and eye movement
training to improve gait in people with progressive supranu-
clear palsy: quasi-randomized clinical trial,” Physical Therapy,
vol. 88, no. 12, pp. 1460–1473, 2008.
[12] C. Zampieri and R. P. Di Fabio, “Improvement of gaze control
after balance and eye movement training in patients with pro-
gressive supranuclear palsy: a quasi-randomized controlled
trial,” Archives of Physical Medicine and Rehabilitation, vol. 90,
no. 2, pp. 263–270, 2009.
[13] T. M. Steffen, B. F. Boeve, L. A. Mollinger-Riemann, and C. M.
Petersen, “Long-term locomotor training for gait and balance
in a patient with mixed progressive supranuclear palsy and
corticobasal degeneration,” Physical Therapy, vol. 87, no. 8, pp.
1078–1087, 2007.
[14] M. Landers, M. Adams, K. Acosta, and A. Fox, “Challenge-
oriented gait and balance training in sporadic olivopontocere-
bellar atrophy: a case study,” Journal of Neurologic Physical
Therapy, vol. 33, no. 3, pp. 160–168, 2009.
[15] F. M. Wedge, “The impact of resistance training on balance
and functional ability of a patient with multiple system
atrophy,” Journal of Geriatric Physical Therapy, vol. 31, no. 2,
pp. 79–83, 2008.
[16] K. Kawahira, T. Noma, J. Iiyama, S. Etoh, A. Ogata, and M.
Shimodozono, “Improvements in limb kinetic apraxia by re-
petition of a newly designed facilitation exercise in a patient
with corticobasal degeneration,” International Journal of Reha-
bilitation Research, vol. 32, no. 2, pp. 178–183, 2009.
6 Parkinson’s Disease
[17] S. Jain, J. Dawson, N. P. Quinn, and E. D. Playford, “Occupa-
tional therapy in multiple system atrophy: a pilot randomized
controlled trial,” Movement Disorders, vol. 19, no. 11, pp.
1360–1364, 2004.
[18] T. Ellis, D. I. Katz, D. K. White, T. J. DePiero, A. D. Hohler,
and M. Saint-Hilaire, “Effectiveness of an inpatient multidis-
ciplinary rehabilitation program for people with Parkinson
disease,” Physical Therapy, vol. 88, no. 7, pp. 812–819, 2008.
[19] K. J. Ottenbacher, Y. Hsu, C. V. Granger, and R. C. Fiedler,
“The reliability of the functional independence measure:
a quantitative review,” Archives of Physical Medicine and
Rehabilitation, vol. 77, no. 12, pp. 1226–1232, 1996.
[20] K. E. Light, A. Behrman, M. Thigpen, and W. Triggs, “The 2-
minute walk test: a tool for evaluating walking endurance in
clients with Parkinson’s disease,” Journal of Neurologic Physical
Therapy, vol. 21, no. 4, pp. 136–139, 1997.
[21] S.Morris, M. E.Morris, and R. Iansek, “Reliability of measure-
ments obtained with the timed “Up, & Go” test in people with
Parkinson disease,” Physical Therapy, vol. 81, no. 2, pp. 810–
818, 2001.
[22] M. Conradsson, L. Lundin-Olsson, N. Lindelo¨f et al., “Berg
balance scale: intrarater test-retest reliability among older
people dependent in activities of daily living and living in resi-
dential care facilities,” Physical Therapy, vol. 87, no. 9, pp.
1155–1163, 2007.
[23] A. A. Qutubuddin, P. O. Pegg, D. X. Cifu, R. Brown, S.
McNamee, and W. Carne, “Validating the Berg balance scale
for patients with Parkinson’s disease: a key to rehabilitation
evaluation,” Archives of Physical Medicine and Rehabilitation,
vol. 86, no. 4, pp. 789–792, 2005.
[24] T. J. Stevenson, “Detecting change in patients with stroke using
the Berg balance scale,” Australian Journal of Physiotherapy,
vol. 47, no. 1, pp. 20–38, 2001.
[25] T. Steffen and M. Seney, “Test-retest reliability and minimal
detectable change on balance and ambulation tests, the 36-
item short-form health survey, and the unified Parkinson
disease rating scale in people with parkinsonism,” Physical
Therapy, vol. 88, no. 6, pp. 733–746, 2008.
[26] I. Shimoyama, T. Ninchoji, and K. Uemura, “The finger-
tapping test. A quantitative analysis,” Archives of Neurology,
vol. 47, no. 6, pp. 681–684, 1990.
[27] M. E. Morris, C. L. Martin, and M. L. Schenkman, “Striding
out with Parkinson disease: evidence-based physical therapy
for gait disorders,” Physical Therapy, vol. 90, no. 2, pp. 280–
288, 2010.
[28] A. Nieuwboer, G. Kwakkel, L. Rochester et al., “Cueing train-
ing in the home improves gait-related mobility in Parkinson’s
disease: the RESCUE trial,” Journal of Neurology, Neurosurgery
and Psychiatry, vol. 78, no. 2, pp. 134–140, 2007.
[29] R. Marchese, M. Diverio, F. Zucchi, C. Lentino, and G.
Abbruzzese, “The role of sensory cues in the rehabilitation of
Parkinsonian patients: a comparison of two physical therapy
protocols,” Movement Disorders, vol. 15, no. 5, pp. 879–883,
2000.
[30] M. H. Thaut, G. C. McIntosh, R. R. Rice, R. A. Miller, J. Rath-
bun, and J. M. Brault, “Rhythmic auditory stimulation in gait
training for Parkinson’s disease patients,” Movement Disorders,
vol. 11, no. 2, pp. 193–200, 1996.
[31] M. A. Hirsch, T. Toole, C. G. Maitland, and R. A. Rider,
“The effects of balance training and high-intensity resistance
training on persons with idiopathic Parkinson’s disease,” Ar-
chives of Physical Medicine and Rehabilitation, vol. 84, no. 8,
pp. 1109–1117, 2003.
[32] T. Ellis, C. J. de Goede, R. G. Feldman, E. C. Wolters, G. Kwak-
kel, and R. C. Wagenaar, “Efficacy of a physical therapy pro-
gram in patients with Parkinson’s disease: a randomized con-
trolled trial,” Archives of Physical Medicine and Rehabilitation,
vol. 86, no. 4, pp. 626–632, 2005.
[33] V. Mu¨ller, B. Mohr, R. Rosin, F. Pulvermu¨ller, F. Mu¨ller, and
N. Birbaumer, “Short-term effects of behavioral treatment
on movement initiation and postural control in Parkinson’s
disease: a controlled clinical study,” Movement Disorders, vol.
12, no. 3, pp. 306–314, 1997.
[34] L. E. Dibble, T. F. Hale, R. L. Marcus, J. Droge, J. P. Gerber,
and P. C. LaStayo, “High-intensity resistance training amplifies
muscle hypertrophy and functional gains in persons with
Parkinson’s disease,” Movement Disorders, vol. 21, no. 9, pp.
1444–1452, 2006.
[35] M. Schenkman, T. M. Cutson, M. Kuchibhatla et al., “Exercise
to improve spinal flexibility and function for people with
Parkinson’s disease: a randomized, controlled trial,” Journal of
the American Geriatrics Society, vol. 46, no. 10, pp. 1207–1216,
1998.
[36] C. L. Comella, G. T. Stebbins, N. Brown-Toms, and C. G.
Goetz, “Physical therapy and Parkinson’s disease: a controlled
clinical trial,” Neurology, vol. 44, no. 3, pp. 376–378, 1994.
[37] S. Sapir, L. O. Ramig, P. Hoyt, S. Countryman, C. O’Brien,
and M. Hoehn, “Speech loudness and quality 12 months after
intensive voice treatment (LSVT) for Parkinson’s disease:
a comparison with an alternative speech treatment,” Folia
Phoniatrica et Logopaedica, vol. 54, no. 6, pp. 296–303, 2002.
[38] L. O. Ramig, C. Fox, and S. Sapir, “Parkinson’s disease: speech
and voice disorders and their treatment with the Lee Silverman
voice treatment,” Seminars in Speech and Language, vol. 25, no.
2, pp. 169–180, 2004.
[39] M. Beninato, K. M. Gill-Body, S. Salles, P. C. Stark, R. M.
Black-Schaffer, and J. Stein, “Determination of the minimal
clinically important difference in the FIM instrument in pa-
tients with stroke,” Archives of Physical Medicine and Rehabili-
tation, vol. 87, no. 1, pp. 32–39, 2006.
[40] M. E.Morris, R. Iansek, and B. Kirkwood, “A randomized con-
trolled trial of movement strategies compared with exercise for
people with Parkinson’s disease,” Movement Disorders, vol. 24,
no. 1, pp. 64–71, 2009.
